NZ183130A - Azetidine-,pyrrolidine- or piperidine-2-carboxylic acid derivatives and pharmaceutical compositions - Google Patents

Azetidine-,pyrrolidine- or piperidine-2-carboxylic acid derivatives and pharmaceutical compositions

Info

Publication number
NZ183130A
NZ183130A NZ183130A NZ18313077A NZ183130A NZ 183130 A NZ183130 A NZ 183130A NZ 183130 A NZ183130 A NZ 183130A NZ 18313077 A NZ18313077 A NZ 18313077A NZ 183130 A NZ183130 A NZ 183130A
Authority
NZ
New Zealand
Prior art keywords
formula
azetidine
pyrrolidine
piperidine
carboxylic acid
Prior art date
Application number
NZ183130A
Other languages
English (en)
Inventor
D W Cushman
M A Ondetti
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/657,792 external-priority patent/US4046889A/en
Priority claimed from US05/751,851 external-priority patent/US4105776A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NZ183130A publication Critical patent/NZ183130A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ183130A 1976-02-13 1977-01-19 Azetidine-,pyrrolidine- or piperidine-2-carboxylic acid derivatives and pharmaceutical compositions NZ183130A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/657,792 US4046889A (en) 1976-02-13 1976-02-13 Azetidine-2-carboxylic acid derivatives
US69843276A 1976-06-21 1976-06-21
US05/751,851 US4105776A (en) 1976-06-21 1976-12-22 Proline derivatives and related compounds

Publications (1)

Publication Number Publication Date
NZ183130A true NZ183130A (en) 1979-08-31

Family

ID=27417986

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183130A NZ183130A (en) 1976-02-13 1977-01-19 Azetidine-,pyrrolidine- or piperidine-2-carboxylic acid derivatives and pharmaceutical compositions

Country Status (31)

Country Link
JP (1) JPS604815B2 (US20030199744A1-20031023-C00003.png)
AR (4) AR222445A1 (US20030199744A1-20031023-C00003.png)
AT (1) AT365569B (US20030199744A1-20031023-C00003.png)
AU (1) AU509899B2 (US20030199744A1-20031023-C00003.png)
BG (3) BG37074A3 (US20030199744A1-20031023-C00003.png)
CA (1) CA1101864A (US20030199744A1-20031023-C00003.png)
CH (3) CH622503A5 (US20030199744A1-20031023-C00003.png)
DD (1) DD129442B3 (US20030199744A1-20031023-C00003.png)
DE (2) DE2759862C2 (US20030199744A1-20031023-C00003.png)
DK (1) DK157487C (US20030199744A1-20031023-C00003.png)
ES (5) ES455803A1 (US20030199744A1-20031023-C00003.png)
FI (1) FI66596C (US20030199744A1-20031023-C00003.png)
FR (1) FR2340932A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1576161A (US20030199744A1-20031023-C00003.png)
GR (1) GR69811B (US20030199744A1-20031023-C00003.png)
HK (1) HK20281A (US20030199744A1-20031023-C00003.png)
HU (1) HU181965B (US20030199744A1-20031023-C00003.png)
IE (1) IE44707B1 (US20030199744A1-20031023-C00003.png)
IL (1) IL51297A (US20030199744A1-20031023-C00003.png)
IT (1) IT1062293B (US20030199744A1-20031023-C00003.png)
KE (1) KE3136A (US20030199744A1-20031023-C00003.png)
MY (2) MY8200075A (US20030199744A1-20031023-C00003.png)
NL (1) NL168509C (US20030199744A1-20031023-C00003.png)
NO (1) NO146985C (US20030199744A1-20031023-C00003.png)
NZ (1) NZ183130A (US20030199744A1-20031023-C00003.png)
PH (1) PH12970A (US20030199744A1-20031023-C00003.png)
PL (1) PL118161B1 (US20030199744A1-20031023-C00003.png)
RO (1) RO69941A (US20030199744A1-20031023-C00003.png)
SE (2) SE423812B (US20030199744A1-20031023-C00003.png)
SU (1) SU747422A3 (US20030199744A1-20031023-C00003.png)
YU (1) YU40664B (US20030199744A1-20031023-C00003.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206122A (en) * 1978-04-14 1980-06-03 E. R. Squibb & Sons, Inc. Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4053651A (en) 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4129566A (en) * 1978-02-15 1978-12-12 E. R. Squibb & Sons, Inc. Derivatives of dehydrocyclicimino acids
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
FR2412537A1 (fr) * 1977-12-22 1979-07-20 Science Union & Cie Nouveaux thiobutyramides substitues, leurs procedes d'obtention et leur application pharmaceutique
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
PH15381A (en) * 1978-02-21 1982-12-17 Squibb & Sons Inc Halogen substituted mercaptoacylamino acids
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
CA1109475A (en) * 1978-07-27 1981-09-22 Miguel A. Ondetti Thiopropanoylamino acid derivatives
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NZ190995A (en) * 1978-09-05 1982-03-09 American Cyanamid Co Substituted omega propionyl or butyryl l-prolines and pharmaceutical compositions
NL7809121A (nl) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw Optisch aktieve derivaten van mercapto-isoboterzuur.
NL7809120A (nl) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw Werkwijze voor de bereiding van proline-derivaten.
GR73585B (US20030199744A1-20031023-C00003.png) * 1978-09-11 1984-03-26 Univ Miami
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4690937A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
JPS5540622A (en) * 1978-09-14 1980-03-22 Santen Pharmaceut Co Ltd Hypotensive agent
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
US4198515A (en) * 1978-12-08 1980-04-15 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
US4347371A (en) * 1978-12-30 1982-08-31 Santen Pharmaceutical Co., Ltd. Disulfide compounds
US4410542A (en) 1978-12-30 1983-10-18 Santen Pharmaceutical Co., Ltd. Disulfide compounds
CA1138452A (en) * 1979-01-15 1982-12-28 John Krapcho Carbamate derivatives of mercaptoacyl hydroxy prolines
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
US4220791A (en) * 1979-03-08 1980-09-02 E. R. Squibb & Sons, Inc. Mercaptoacylpyrazolidinone carboxylic acid derivatives
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
US4234489A (en) * 1979-06-25 1980-11-18 E. R. Squibb & Sons, Inc. Pyroglutamic acid derivatives and analogs
JPS5629403U (US20030199744A1-20031023-C00003.png) * 1979-08-13 1981-03-20
DE2937779A1 (de) * 1979-09-19 1981-04-09 Hoechst Ag, 6000 Frankfurt Aminosaeurederivate und verfahren zu ihrer herstellung
GB2066240A (en) * 1979-12-10 1981-07-08 Squibb & Sons Inc Derivatives of mercaptoacyl amino acids
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
GB2065643B (en) * 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents
SE431331B (sv) * 1980-03-21 1984-01-30 Squibb & Sons Inc Nya terapeutiskt aktiva svavelinnehallande n-acylerade derivat av 4-oxo-l-prolin
DE3011239A1 (de) * 1980-03-22 1981-10-01 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte alkylthioacylaminosaeuren, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
SE8203245L (sv) * 1981-05-27 1982-11-28 Crc Ricerca Chim Forfarande for enantioselektiv framstellning av n-substituerade prolinderivat
KR860001391B1 (ko) * 1984-07-23 1986-09-22 보령제약 주식회사 피롤리딘 유도체의 제조방법
JPH06740B2 (ja) * 1984-08-16 1994-01-05 三菱レイヨン株式会社 光学活性カルボン酸アミドの製造法
HU196369B (en) * 1984-10-18 1988-11-28 Egyt Gyogyszervegyeszeti Gyar New process for producing n-acylized l-prolin derivatives
KR870001570B1 (ko) * 1984-12-19 1987-09-04 보령제약 주식회사 피롤리딘 유도체의 제조방법
KR870001569B1 (ko) * 1985-02-11 1987-09-04 보령제약 주식회사 피롤리딘 유도체의 제조방법
AT395012B (de) * 1986-06-27 1992-08-25 Richter Gedeon Vegyeszet Verfahren zur herstellung von n-(1(s)|thoxycarbonyl-3-phenyl-propyl)-(s)-alanyl-(s)prolin und von dessen saeureadditionssalzen
JP2863534B2 (ja) * 1988-10-24 1999-03-03 マリオン ラボラトリーズ,インコーポレイティド 医薬組成物
US5026873A (en) * 1989-11-06 1991-06-25 E. R. Squibb & Sons, Inc. Process for direct isolation of captopril
DE4228455A1 (de) * 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
EP0656773B1 (de) * 1992-08-26 1997-04-02 Beiersdorf Aktiengesellschaft Verwendung von radikalfängern als immunmodulierende agentien in kosmetischen und dermatologischen zubereitungen
IT1266570B1 (it) * 1993-07-30 1997-01-09 Zambon Spa Derivati della propanammide n-eteroaril sostituiti utili nel trattamento delle malattie cardiovascolari
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
GB9704522D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
SI0915088T1 (en) 1997-10-31 2002-12-31 F. Hoffmann-La Roche Ag D-proline derivatives
CA2457814A1 (en) * 2001-08-07 2003-02-20 Sunesis Pharmaceuticals, Inc. Disulfide and thiosulfonate ligands and libraries comprising these ligands
CN100361971C (zh) * 2005-09-19 2008-01-16 华中师范大学 催化活性可调的双官能团l-脯氨酸衍生物及制备
MX2011001887A (es) 2008-08-22 2011-04-04 Baxter Int Derivados de bencil carbonato polimericos.
EP2852284A4 (en) 2012-04-27 2016-05-04 Dow Agrosciences Llc PESTICIDAL COMPOSITIONS AND CORRESPONDING METHODS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA946836A (en) * 1970-03-18 1974-05-07 Miguel A. Ondetti Enzyme inhibitor

Also Published As

Publication number Publication date
AT365569B (de) 1982-01-25
ES467050A1 (es) 1978-11-01
DD129442B3 (de) 1990-01-10
SE8104660L (sv) 1981-08-03
CH624931A5 (US20030199744A1-20031023-C00003.png) 1981-08-31
AU2134777A (en) 1978-07-20
DK157487C (da) 1990-06-11
AR222783A1 (es) 1981-06-30
DE2759862C2 (US20030199744A1-20031023-C00003.png) 1989-12-07
ATA98977A (de) 1981-06-15
IL51297A0 (en) 1977-03-31
SE7701561L (sv) 1977-09-23
CA1101864A (en) 1981-05-26
MY102705A (en) 1992-09-30
AR222445A1 (es) 1981-05-29
IL51297A (en) 1980-03-31
SE423812B (sv) 1982-06-07
BG37375A3 (en) 1985-05-15
FI66596C (fi) 1987-03-18
PL195965A1 (pl) 1978-02-27
AR214649A1 (es) 1979-07-13
FI66596B (fi) 1984-07-31
GR69811B (US20030199744A1-20031023-C00003.png) 1982-07-13
YU40664B (en) 1986-04-30
ES467052A1 (es) 1978-11-01
CH622503A5 (en) 1981-04-15
MY8200075A (en) 1982-12-31
DE2703828A1 (de) 1977-08-18
SE426697B (sv) 1983-02-07
BG37074A3 (en) 1985-03-15
PL118161B1 (en) 1981-09-30
DE2703828C2 (de) 1984-06-20
IE44707L (en) 1977-08-13
CH624932A5 (US20030199744A1-20031023-C00003.png) 1981-08-31
FR2340932A1 (fr) 1977-09-09
NL168509C (nl) 1982-04-16
KE3136A (en) 1981-07-03
DK59677A (da) 1977-08-14
NL7701457A (nl) 1977-08-16
BG37075A3 (en) 1985-03-15
FR2340932B1 (US20030199744A1-20031023-C00003.png) 1981-02-06
ES455803A1 (es) 1978-06-16
NO146985B (no) 1982-10-04
GB1576161A (en) 1980-10-01
RO69941A (ro) 1980-05-15
DD129442A5 (de) 1978-01-18
AR226290A1 (es) 1982-06-30
NO770464L (no) 1977-08-16
HU181965B (en) 1983-11-28
JPS52116457A (en) 1977-09-29
JPS604815B2 (ja) 1985-02-06
FI770437A (US20030199744A1-20031023-C00003.png) 1977-08-14
ES467051A1 (es) 1978-11-01
HK20281A (en) 1981-05-22
IE44707B1 (en) 1982-03-10
IT1062293B (it) 1984-05-23
YU33177A (en) 1983-01-21
NO146985C (no) 1983-01-12
AU509899B2 (en) 1980-05-29
ES467053A1 (es) 1978-11-01
SU747422A3 (ru) 1980-07-23
DK157487B (da) 1990-01-15
PH12970A (en) 1979-10-24

Similar Documents

Publication Publication Date Title
NZ183130A (en) Azetidine-,pyrrolidine- or piperidine-2-carboxylic acid derivatives and pharmaceutical compositions
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
FI860369A0 (fi) Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
SE8305160L (sv) Antibakteriella emnen
MX9202782A (es) Compuesto triciclos y composiciones farmaceuticas que lo contienen.
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
NO303817B1 (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
GB1420758A (en) Anti-ulcer compositions
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
NO903084D0 (no) Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling.
DE3784883D1 (de) Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.